Breast imaging market was valued US$ 2.82 Bn in 2017 and is expected to reach US$ 5.43 Bn by 2026, at a CAGR of 8.53% during a forecast period. The global breast imaging market is categorized into technologies and region. On the basis of technologies, the global breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies market.
Further, the ionizing breast imaging technologies segment is sub-segmented into Analog Mammography, Full-Field Digital Mammography, 3D Breast Tomosynthesis, Positron Emission Tomography & Computed Tomography, Molecular Breast Imaging & Breast-Specific Gamma Imaging, Cone Beam Computed Tomography, Positron Emisssion Mammography, and Electric Impedance Tomography. The non-ionizing breast imaging technologies segment includes breast MRI, breast ultrasound, optical imaging, automated whole-breast ultrasound, and breast thermography. Based on regions, the global breast imaging market is divided into five main regions are America, Europe, Asia-pacific, Latin America and Middle East & Africa.
Based on product type, the ionizing breast imaging technologies, 3D breast tomosynthesis segment is expected to grow at the highest CAGR during the forecast period owing to the increasing regulatory approvals for 3D breast tomosythesis systems, benefits offered by these systems over other technologies, and higher patient accessibility offered by these systems. The non-ionizing breast imaging technologies, automated whole-breast ultrasound segment is expected to grow at the highest CAGR during the forecast period due to the high reproducibility, high-resolution power with 3D capability, lower false positives, and faster imaging.